SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-12-000917
Filing Date
2012-05-04
Accepted
2012-05-04 13:48:44
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 medizone10q033112.htm 10-Q 483272
2 ex31-1.htm EX-31.1 9962
3 ex31-2.htm EX-31.2 10443
4 ex32-1.htm EX-32.1 5197
5 ex32-2.htm EX-32.2 5077
  Complete submission text file 0001185185-12-000917.txt   1805895

Data Files

Seq Description Document Type Size
6 mzei-20120331.xml EX-101.INS 129136
7 mzei-20120331.xsd EX-101.SCH 15714
8 mzei-20120331_cal.xml EX-101.CAL 34617
9 mzei-20120331_def.xml EX-101.DEF 86543
10 mzei-20120331_lab.xml EX-101.LAB 113526
11 mzei-20120331_pre.xml EX-101.PRE 88920
Mailing Address 2330 MARINSHIP WAY SUITE 300 SAUSALITO CA 94965
Business Address 2330 MARINSHIP WAY SUITE 300 SAUSALITO CA 94965 (415) 331-0303
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 002-93277-D | Film No.: 12813403
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries